Colorectal cancer is the second leading cause of cancer-related deaths for males and females. Screening for colorectal cancer ...
BERLIN -- The investigational tyrosine kinase inhibitor (TKI) zanzalintinib plus atezolizumab (Tecentriq) significantly ...